Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Molecular Pharmacology (USA) Ltd. Stock Analysis MLPH
United States N/A Nano Cap Molecular Pharmacology (USA) Ltd. is a shell company. The company is headquartered in Leederville, Western Australia. The company went IPO on 2005-05-20. The firm is not engaged in any business activities.
Read More Molecular Pharmacology (USA) Ltd (MLPH) Chart
Key Statistics of Molecular Pharmacology (USA) Ltd (MLPH)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.02Volume
125.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
999.55KAvg. Volume
25.27KDividend Yield
-Financial Metrics & Statements of Molecular Pharmacology (USA) Ltd (MLPH)
FAQ's for Molecular Pharmacology (USA) Ltd (MLPH)
- According to Musaffa’s Shariah screening methodology, Molecular Pharmacology (USA) Ltd (MLPH) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Molecular Pharmacology (USA) Ltd using these criteria to determine its compliance status.
- Muslim investors may consider investing in Molecular Pharmacology (USA) Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Molecular Pharmacology (USA) Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Molecular Pharmacology (USA) Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Molecular Pharmacology (USA) Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.